To evaluate the role of TNF-α derived from Cl-IB-MECA-treated CD8+ T cells, CD8+ T cells were transferred into melanoma bearing mice receiving a neutralizing monoclonal antibody (mAb) against TNF-α. Here, CD8A is linked to melanoma.